130 related articles for article (PubMed ID: 9248957)
21. Broad- versus narrow-spectrum antibiotic use: the role of in vitro testing and its correlation with clinical efficacy.
Mouton Y; Senneville E
Postgrad Med J; 1992; 68 Suppl 3():S68-72. PubMed ID: 1287621
[TBL] [Abstract][Full Text] [Related]
22. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.
Kollef MH
Clin Infect Dis; 2000 Sep; 31 Suppl 4():S131-8. PubMed ID: 11017862
[TBL] [Abstract][Full Text] [Related]
23. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.
Kubanova A; Frigo N; Kubanov A; Sidorenko S; Priputnevich T; Vachnina T; Al-Khafaji N; Polevshikova S; Solomka V; Domeika M; Unemo M
Sex Transm Infect; 2008 Aug; 84(4):285-9. PubMed ID: 18256105
[TBL] [Abstract][Full Text] [Related]
24. Using internet discussion of antimicrobial susceptibility databases for continuous quality improvement of the testing and management of antimicrobial resistance.
O'Brien TF; Eskildsen MA; Stelling JM
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S118-23. PubMed ID: 11524707
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial resistance profile of bacterial isolates from Intensive Care Unit: changing trends.
Anupurba S; Sen MR
J Commun Dis; 2005 Mar; 37(1):58-65. PubMed ID: 16637402
[TBL] [Abstract][Full Text] [Related]
26. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?
Breuer T; Graham DY
Am J Gastroenterol; 1999 Mar; 94(3):725-9. PubMed ID: 10086658
[TBL] [Abstract][Full Text] [Related]
27. Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy.
Schifman RB; Pindur A; Bryan JA
Arch Pathol Lab Med; 1997 Nov; 121(11):1168-70. PubMed ID: 9372743
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic synergy testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms.
Aaron SD
Paediatr Respir Rev; 2007 Sep; 8(3):256-61. PubMed ID: 17868924
[TBL] [Abstract][Full Text] [Related]
29. Update on clinical antifungal susceptibility testing for Candida species.
Lewis RE; Klepser ME; Pfaller MA
Pharmacotherapy; 1998; 18(3):509-15. PubMed ID: 9620102
[TBL] [Abstract][Full Text] [Related]
30. Characterization of antimicrobial resistance of foodborne Listeria monocytogenes.
Conter M; Paludi D; Zanardi E; Ghidini S; Vergara A; Ianieri A
Int J Food Microbiol; 2009 Jan; 128(3):497-500. PubMed ID: 19012982
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility testing: a primer for clinicians.
Kuper KM; Boles DM; Mohr JF; Wanger A
Pharmacotherapy; 2009 Nov; 29(11):1326-43. PubMed ID: 19857149
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas.
White RL; Friedrich LV; Mihm LB; Bosso JA
Clin Infect Dis; 2000 Jul; 31(1):16-23. PubMed ID: 10913390
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial resistance in pediatric upper respiratory infection: a prescription for change.
Lang MM
Pediatr Nurs; 1999; 25(6):607-16. PubMed ID: 12024379
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
[TBL] [Abstract][Full Text] [Related]
35. Should we reevaluate antibiotic breakpoints?
Ferraro MJ
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S227-9. PubMed ID: 11524723
[TBL] [Abstract][Full Text] [Related]
36. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients].
Stephan C; Just-Nübling G; Franck S; Bickel M; Shah PM; Babacan E; Staszewski S
Med Klin (Munich); 2008 Feb; 103(2):69-74. PubMed ID: 18270662
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
[TBL] [Abstract][Full Text] [Related]
38. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Bennett KM; Scarborough JE; Sharpe M; Dodds-Ashley E; Kaye KS; Hayward TZ; Vaslef SN
J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic susceptibility testing of Bifidobacterium thermophilum and Bifidobacterium pseudolongum strains: broth microdilution vs. agar disc diffusion assay.
Domig KJ; Mayrhofer S; Zitz U; Mair C; Petersson A; Amtmann E; Mayer HK; Kneifel W
Int J Food Microbiol; 2007 Nov; 120(1-2):191-5. PubMed ID: 17884216
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
